A Phase I/II Trial of combined adjuvant therapy with gemcitabine and cisplatin for resected biliary tract cancer
Not Applicable
Recruiting
- Conditions
- Resected biliary tract cancer
- Registration Number
- JPRN-UMIN000004359
- Lead Sponsor
- Shinshu University School of Medicine, Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
Interstitial pneumonia heart failure ascites and edema Infection diabetes mellitus Allergy of the drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method efficacy